1
Levetiracetam for Alzheimer’s Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)
Condition(s):Alzheimer DiseaseLast Updated:July 2, 2019Not yet recruiting
Levetiracetam: 266 Clinical Trials, Page 1 of 27
Hide Studies Not Open or Pending
2
An Investigation of Levetiracetam in Alzheimer’s Disease
Condition(s):Alzheimer Disease; EpilepsyLast Updated:April 28, 2021Active, not recruiting
3
Levetiracetam in Early Psychosis
Condition(s):Psychosis; Schizophrenia; Schizo Affective Disorder; SchizophreniformLast Updated:November 11, 2021Recruiting
4
R33: Levetiracetam in Early Psychosis
Condition(s):Early PsychosisLast Updated:May 25, 2022Recruiting
5
Modified Atkins Diet Versus Levetiracetam for Refractory Childhood Epilepsy
Condition(s):Refractory Childhood EpilepsyLast Updated:November 21, 2019Unknown status
6
Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG
Condition(s):Neonatal SeizuresLast Updated:April 11, 2017Unknown status
7
Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
Condition(s):Glioblastoma MultiformeLast Updated:June 28, 2016Unknown status
8
A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age
Condition(s):Partial SeizuresLast Updated:March 11, 2022Active, not recruiting
9
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
Condition(s):Neonatal SeizuresLast Updated:August 21, 2019Completed
10
Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease
Condition(s):Epilepsy; Diabetic NephropathyLast Updated:April 15, 2022Enrolling by invitation